Clinical Trial Update: Study Evaluating the Efficacy and Safety With CAR-T Immunotherapy for CD19 Positive Lymphoma [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study evaluating the efficacy and safety of a CD19-targeted CAR-T therapy for lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• CD19-targeted CAR-T Therapy

Snippet

Sponsor: Sinobioway Cell Therapy Co., Ltd. | Conditions: Lymphoma | Phase 1 | Status: UNKNOWN